IF
TEVA icon

Ironwood Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Ironwood Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50
Closed – – 492
2021
Q3 		$0 Hold
50
– – ﹤0.01% 598
2021
Q2 		$0 Hold
50
– – ﹤0.01% 585
2021
Q1 		$1K Hold
50
– – ﹤0.01% 521
2020
Q4 		$0 Buy
+50
New +$479 ﹤0.01% 502
2020
Q1 		– Sell
-100
Closed -$1K – 406
2019
Q4 		$1K Hold
100
– – ﹤0.01% 367
2019
Q3 		$1K Hold
100
– – ﹤0.01% 371
2019
Q2 		$1K Hold
100
– – ﹤0.01% 367
2019
Q1 		$2K Hold
100
– – ﹤0.01% 348
2018
Q4 		$2K Hold
100
– – ﹤0.01% 341
2018
Q3 		$2K Buy
+100
New +$2.32K ﹤0.01% 338
2015
Q3 		$3K Buy
+60
New +$3.89K ﹤0.01% 315

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ironwood Financial's TEVA Position: Q4 2021 in Review

Ironwood Financial sold out of Teva Pharmaceuticals (TEVA) in Q4 2021, closing a stake of 50 shares.

Ironwood Financial first reported a position in TEVA in Q3 2015 and held it in 11 quarters. The position peaked at $3K in Q3 2015. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Ironwood Financial reported no remaining Teva Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Ironwood Financial sold 50 Teva Pharmaceuticals shares in Q4 2021.
  • Ironwood Financial first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 11 quarters.
  • Ironwood Financial's Teva Pharmaceuticals position peaked at $3K in Q3 2015.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.